I’m here and looking to add soon but being patient awaiting more Board changes that I think will come Despite recent sights of Tarriff digging in more (again it was a huge mistake whatever large investor(s) switched their Cooper & Tarriff Board votes on proxy last minute to allow them to get more “for” than “withheld“ or I think the changes would have been done already). While I agree with Chris they need to start a damn trial or two my opinion is same as a month ago that until Tarriff and more board members are replaced by people the largest holders are happy about, the money on the sidelines itching to buy the dip including some large guys are being patient waiting for change. James Huang was a good start and imo liked by large holders maybe even driven by them. This last board swap was a joke and I think they changed bylaws also to dig in more
Tarriff is dug in but I think he still we be thrown out. If so that will bring a lot of buyers, hopefully followed by an R&D day with June/Rosenberg actually officially announced with an agenda showing them on vs the rumors of that. Then maybe we continue momentum of board change and then hopefully actually dosing of trials in Q4. I have been saying for months I’m hoping Q4 is the quarter for ZIOP to regain momentum - Board changes including Chairman would be a big jump start followed hopefully by a meaningful RD if they can get the two immunotherapy superstars on agenda (actually officially in and on an agenda, not a rumor) and trial actually dosing not talk about dosing.